2seventy bio, Inc. (TSVT)
(Delayed Data from NSDQ)
$4.40 USD
+0.06 (1.38%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $4.40 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum D VGM
2seventy bio, Inc. (TSVT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$9.20 | $15.00 | $2.00 | 111.98% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for 2seventy bio, Inc. comes to $9.20. The forecasts range from a low of $2.00 to a high of $15.00. The average price target represents an increase of 111.98% from the last closing price of $4.34.
Analyst Price Targets (5 )
Broker Rating
2seventy bio, Inc. currently has an average brokerage recommendation (ABR) of 2.43 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 2.43 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, three are Strong Buy, representing 42.86% of all recommendations. A month ago, Strong Buy represented 42.86%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.43 | 2.43 | 2.43 | 2.43 | 2.43 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
10/22/2024 | Cowen & Co. | Yaron Werber | Hold | Hold |
9/26/2024 | SVB Securities | Daina M Graybosch | Strong Buy | Strong Buy |
6/18/2024 | Guggenheim Securities | Kelsey Goodwin | Hold | Hold |
6/6/2024 | Goldman Sachs | Salveen Richter | Hold | Strong Sell |
5/9/2024 | Canaccord Genuity | John L Newman | Not Available | Strong Buy |
4/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.43 |
ABR (Last week) | 2.43 |
# of Recs in ABR | 7 |
Average Target Price | $9.20 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 89 of 252 |
Current Quarter EPS Est: | -0.14 |
TSVT FAQs
2seventy bio, Inc. (TSVT) currently has an average brokerage recommendation (ABR) of 2.43 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for 2seventy bio, Inc. (TSVT) is $9.20. The current on short-term price targets is based on 2 reports.
The forecasts for 2seventy bio, Inc. (TSVT) range from a low of $2 to a high of $15. The average price target represents a increase of $109.09 from the last closing price of $4.40.
The current UPSIDE for 2seventy bio, Inc. (TSVT) is 109.09%
Based on short-term price targets offered by five analysts, the average price target for 2seventy bio, Inc. comes to $9.20. The forecasts range from a low of $2.00 to a high of $15.00. The average price target represents an increase of 111.98% from the last closing price of $4.34.